-
Uncategorized1 month agoSTAT+: Are analysts too quick to gloss over Lilly’s liver case?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I was having...
-
Uncategorized1 month ago
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs
The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.
-
Uncategorized1 month ago
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
Biogen’s Qalsody won FDA approval in 2023 to treat a rare, genetic form of amyotrophic lateral sclerosis. On Tuesday, QurAlis presented interim Phase 2 data showing...
-
Uncategorized1 month ago
Madrigal extends MASH deal streak with Arrowhead drug that J&J didn’t want
Madrigal Pharmaceuticals has made its fourth MASH deal in 10 months, further signaling its ambitions to be not just the first drugmaker for the fatty liver...
-
Uncategorized1 month agoSTAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more
Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear and...
-
Uncategorized1 month ago
Vertex earnings get muted investor response
While overall revenue fell just shy of Wall Street forecasts, sales of the gene editing medicine Casgevy and pain drug Journavx missed analyst estimates by double-digit...
-
Uncategorized1 month ago
Vertex’s quiet Q1 is calm before potentially ‘iconic’ renal evolution
While some analysts may regard Vertex Pharmaceuticals’ first quarter results as “unremarkable,” BMO Capital Markets wrote on Monday, the second half of 2026 could be big...
-
Uncategorized1 month ago
Foundayo’s liver failure blip weighs down Lilly shares. but analysts unconcerned
The selloff in Eli Lilly’s shares was “overdone,” according to RBC Capital Markets, which noted that the overall safety profile of Foundayo remains favorable.
-
Uncategorized1 month ago
New Human-Computer Interaction Software Designed to Support Diverse Online Teamwork Styles
Remote collaboration software tools, such as Zoom or Google Docs, have become essential for teamwork. But they often overlook the fact that people do not all...
-
Uncategorized1 month agoWhat you need to know about hantavirus (don’t panic)
Good morning. Yesterday, the writer Yiyun Li won a Pulitzer Prize for her heartbreaking memoir, “Things in Nature Merely Grow.” Lately, I’ve been reading her short stories....
